VIR is currently covered by 8 analysts with average potential upside of $10.02 (39.13%) backed by 35 price targets and 47 ratings. Documented since 05-Nov-2019. Analyst's average stock valuation to be materialised ratio is 48.51% with an average time for price targets to be met of 139.78 days.
Most recent stock forecast was given by ANUPAM RAMA from JPMORGAN on 06-Mar-2023.
Highest price target for VIR is 51, Lowest price target is 21, average price target is 36.
Currently, out of the existing stock ratings of VIR - 6 which are a Hold (27.27%), 10 which are a Buy (45.45%), 6 which are a Sell (27.27%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
34
$11.4 (50.44%)
37
23 days ago
6/8 (75%)
$-5.84 (2.72%)
124
Buy
100
$77.4 (342.48%)
23 days ago
1/2 (50%)
$57.48 (211.90%)
112
Buy
32
$9.4 (41.59%)
32
1 months 5 days ago
1/6 (16.67%)
$13.48 (47.88%)
159
Buy
53
$30.4 (134.51%)
53
1 months 6 days ago
4/9 (44.44%)
$11.66 (37.42%)
74
Hold
53
$30.4 (134.51%)
24
1 months 8 days ago
4/7 (57.14%)
$-11.49 (-16.61%)
481
What is VIR(Vir Biotechnology Inc.) average time for price targets to be met?
Which analyst has the current highest performing score on VIR(Vir Biotechnology Inc.) with a proven track record?
